Pharma
Politicos and officials must ensure stringent regulation of drugs,...
There is something wrong, terribly wrong, with regulation in India. Either it is so onerous and cumbersome that entrepreneurs get exasperated with the...
Lupin launches new generic drug in US market
Pharma major Lupin Limited announced on Monday that it has launched Mirabegron extended-release tablets, 25 mg, in the United States market, after...
Dr Reddy’s launches programme for IBS
Dr Reddy’s Laboratories Ltd, a city-based pharmaceutical company on Friday announced the roll-out of condition management programme DailyBloom IBS, a...
USFDA issues Form 483
New Delhi: Marksans Pharma Ltd on Thursday said the US health regulator has issued a Form 483 with five inspectional observations after inspecting its...
Tech-led healthcare keeping rural India healthy
Expanding telemedicine, AI & ML-enabled digital health solutions together with govt’s National Digital Health Mission led to reductions in maternal,...
Gland Pharma gets USFDA nod
New Delhi: Gland Pharma on Monday said it has received approval from the US health regulator to market a generic medication used to treat breast...
Go in for influenza vaccine early this year
Influenza strains change constantly because of genetic mutation
Indian drug firms will see 8-10% revenue growth in FY25: Report
New Delhi: Revenue growth of leading 25 domestic drug firms is expected to moderate to 8-10 per cent in the next fiscal year, rating agency Icra...
